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Abstract 
Exercise-induced oxygen desaturation (EID) is related to mortality in patients with 
chronic obstructive pulmonary disease (COPD). We investigated: (1) the prevalence of 
EID; (2) the relative-weight of several physiological determinants of EID including 
pulmonary emphysema, and (3) the relationship of EID with certain patients’ clinical 
characteristics.  
 
Data from 2050 COPD patients (age: 63.3±7.1years; FEV1: 48.7±15.7%pred.) were analyzed. 
The occurrence of EID (SpO2 ≤88%) at the six-minute walking test (6MWT) was 
investigated in association with emphysema quantified by computed-tomography (QCT), 
and several clinical characteristics. 
 
435 patients (21%) exhibited EID. Subjects with EID had more QCT-emphysema, lower 
exercise capacity and worse health-status (BODE, ADO indexes) compared to non-EID. 
The occurrence of EID was progressively increased across emphysema-degrees in GOLD II 
(≤9-fold) but this increase was lower in GOLD III-IV. Determinant of EID were obesity 
(BMI≥30kg/m2), low FEV1 (≤44%pred.), moderate or worse emphysema, and low baseline-
SpO2 (≤93%). Linear regression indicated that each 1-point increase on the ADO-score 
independently elevates odds ratio (≤1.5fold) for EID.  
 
About one in five COPD patients in the ECLIPSE cohort presents EID. Emphysema severity 
is more related to EID in GOLD II compared to GOLD III-IV. In addition, obesity, airflow 
obstruction, and low baseline oxygen saturation increase the odds for EID. 
Emphysematous patients with high ADO-score should be monitored for EID. 
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1. Introduction 
Exercise-induced oxygen desaturation (EID), as defined by fall in oxygen saturation to 
88% or lower during exercise1, 2, can occur in patients with Chronic Obstructive Pulmonary 
Disease (COPD), even in those without resting hypoxemia.3-5 Yet, their physiological 
determinants and clinical consequences are still subject of debate. In general, patients 
with EID are characterized by severe airflow limitation, low diffusing carbon monoxide 
capacity (DLCO), reduced resting arterial oxygenation6-9 and the presence of 
emphysema10-12 In addition, EID is also related to numerous variables that include the rate 
of lung function decline and health status13, physical activity14, and the outcomes of 
hospitalization as well as mortality.15, 16 The determinants of EID, however, have not been 
validated in a large cohort of COPD patients followed up prospectively. The design and 
size of the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate 
Endpoints) study offers a unique opportunity to overcome these limitations.17  
 
 
 
 
 
 
 
 
 
 
 
 
Herein, we investigated in the ECLIPSE: (1) the prevalence of EID in COPD; (2) the relative 
weight of several physiological determinants of EID in COPD, particularly the severity of 
airflow limitation and the presence of emphysema as defined by quantitative computed 
tomography (QCT) analysis18-20; and, (3) the relationship of EID with certain patients’ 
clinical characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Material and Methods 
2.1 Design and participants 
The ECLIPSE study (Clinicaltrials.gov identifier NCT00292552; GSK study code SCO104960) 
was a 3-year non-interventional longitudinal prospective study, as described elsewhere.17 
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In brief, individuals (age: 40-75 years) were recruited to ECLIPSE if they had a smoking 
history of ≥10 pack-years and a diagnosis of COPD.21 We excluded subjects with resting 
hypoxemia (as defined by SpO2% pre-walk≤88%) from this analysis. The ECLIPSE study was 
carried out in accordance with the Declaration of Helsinki and good clinical practice 
guidelines, and was approved by the ethics committees of participating centers. The 
Institutional Review Boards of all participating institutions approved the study and all 
participants provided written informed consent. Data from the ECLIPSE study have been 
published before16, 22-24 but the current analysis, which is mostly focus on EID in 
association with the severity of emphysema, is novel and, therefore, complements 
previous reports. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2 Subject characterization 
 
Demographic and physiological characteristics, level of dyspnoea (using the modified 
Medical Research Council (mMRC) dyspnoea scale)25, measurements of lung function 
(post-bronchodilator spirometry and lung volumes), QCT-emphysema degrees, health 
status (using the St. George’s  Respiratory Questionnaire (SGRQ))26, and data from 
6MWT were used in this analysis. Fat mass and fat free mass were determined using 
bioelectrical impedance (Bodystat 1500). The fat free mass index (FFMI, kg/m2) was 
calculated as the mass (kg) divided by the squared height (m2) and the body mass index 
(BMI, kg/m2) was calculated as weight (kg) divided by squared height (m2). Furthermore, 
the following multidimensional COPD indices were calculated for the whole cohort; (1) 
the ADO index27, which includes age, dyspnoea by the MRC, and FEV1%,  and (2) the  BODE 
index28, which incorporates dyspnoea by the MRC, BMI, FEV1%, and exercise capacity as 
measured by 6-minute walking distance (6MWD). 
 8 
2.3 CT imaging 
All subjects underwent a low-dose volumetric computed tomography (CT scan) at full 
inspiration. Scans were obtained using multi-detector row CT scanners (120 kVp, 40 mAs) 
and were reconstructed using contiguous 1.00 mm or 1.25 mm slice thickness and an 
intermediate spatial frequency reconstruction algorithm. The radiation dose was 
estimated to be 1.67 mSv per CT study or 5 mSv for the entire ECLIPSE protocol. All CT 
scans were sent for evaluation at the central imaging unit at the University of British 
Columbia (Vancouver, BC, Canada).29 All CT scans were analysed by the use of Pulmonary 
Workstation 2.0 software (VIDA Diagnostics, Coralville, IA, USA) and the severity of 
emphysema was quantified in CT scans (QCT) by two radiologists using the % of lung 
pixels that were low attenuation areas (%LAA) defined as being below 950 Hounsﬁeld 
Units (density mask technique).18, 20, 30 The degree of QCT-emphysema was classified 
according to a 5-scale score as absent-trivial: <5% (scores 0-1), mild: 5-25% (score 2), 
moderate: 25-50% (score 3), or severe to very severe: >50% (scores 4-5).29  
 
 
2.4 Six-minute walk test (6MWT) 
The 6MWT was performed according to international recommendations.31 Briefly, 
participants were asked to walk indoors in a flat, straight, 30-meter walking course 
supervised by a well-trained researcher. A practice 6MWT was not undertaken. Patients 
were encouraged using standardized encouragement every minute of the 6MWT.1 
Resting (pre-walk) and post SpO2 were assessed using a pulse oxymeter with a finger 
probe. A modified Borg scale was used to quantify the levels of dyspnoea and fatigue 
perceived by patients at the beginning and end of the test. All subjects included in the 
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analysis were non-hypoxemic at rest (SpO2 pre-walk ≥89%). EID was defined as a fall of 
oxygen saturation to SpO2 ≤88% at the end of the test.
1, 2   
 
 
2.5 Statistical analyses  
Results are reported as mean (standard deviation) or proportion (%). The statistical 
significance of differences between groups was assessed by analysis of variance, paired 
T-tests and Chi-square, as appropriate. Pearson’s correlation coefficients were used to 
assess the bivariate relationship amongst patients’ characteristics and the variables of 
SpO2% post-walk, ΔSpO2% and QCT-defined emphysema. Linear regression and univariate 
and multivariate binary logistical regression models were used to assess individual 
predictors of EID. Receiver operating characteristics (ROC) curves were used to 
determine threshold values to predict EID. The Area Under the curve (AUC) was 
calculated by the trapezoidal rule and the confidence intervals of the AUC was computed 
by the method of DeLong.32  Two-sided level of significance was set at P <0.05. Statistical 
analyses were carried out using MedCalc v.12, Sigmaplot v.12 and SPSS v.19.0. 
 
 
3. Results 
3.1 Subject characteristics  
Two thousand and fifty subjects (n=2050) with COPD were included in the study.             
As shown in Table 1, subjects generally had severe airflow limitation, low oxygen 
saturation (SpO2 pre-walk), and were normal-weight to overweight. A total of 1124 
subjects (55%) were assigned into GOLD III and IV while 622 subjects (33%) were 
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diagnosed with severe to very severe emphysema. Fifty three percent (53%) of the 
subjects complained of severe dyspnoea (mMRC scale ≥2), and 47% had severely impaired 
health status (SGRQ Total Score ≥50). Thirty six percent (36%) were current smokers 
(Table 1). 
 
3.2 Determinants of EID  
A total of 435 subjects (21%) exhibited EID while the prevalence of EID was higher across 
GOLD stages (Figure 1). Subjects with EID were older with more severe airflow limitation, 
lower FVC, and worse mMRC dyspnoea and SGRQ total scores. Also, they were more 
commonly ex-smokers compared those without EID (non-EID; Table 1). Subjects with EID 
had a shorter walk distance (6MWD), lower pre-walk SpO2 and higher pre/post-walk 
heart rate. In addition, EID subjects had greater increase of heart rate from baseline 
(HR) and more intense exertional dyspnoea compared to non-EID (Table 2). Moreover, 
those with EID had higher scores of the ADO index 27 and the BODE index 28 compared to 
non-EID subjects (Table 2).  
 
The effect of QCT-emphysema on the lowest values of oxygen saturation levels, which 
defined the EID (SpO2 decline ≤88%) in the 6MWT, seems to be greater in GOLD stages II 
compared to GOLD stages III-IV (Figure 2). Occurrence of EID was increased progressively 
across emphysema severity in GOLD II by a factor of up to 9 but this relative increase was 
lower and not distinctively progressive in GOLD III-IV. Both, severity of airflow limitation 
and the extent of emphysema had a negative impact on the SpO2 levels at the end of 
6MWT. 
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3.3 Multivariate correlates of EID  
Using receiver operating characteristics (ROC) curves, the threshold values with the best 
specificity and sensitivity to predict EID were determined for age (≥60 years), sex 
(female), BMI (≥30 kg/m2), FEV1 (≤44% predicted), QCT-emphysema (moderate to very 
severe), resting oxygen saturation (SpO2 pre-walk ≤93%) and ADO index (ADO score ≥6 
points; Online table 1). Univariate logistical regression analysis revealed that older age 
and impaired levels of FEV1, QCT-emphysema, and SpO2 pre-walk were independent 
predictors of EID. Multivariate logistical regression model showed that only impaired 
levels of FEV1, QCT-emphysema, and SpO2 pre-walk remained significant (p ≤0.016). 
Interestingly, BMI (obesity) reached statistical significance (p <0.003) for contributing 
EID only within this multivariate-adjusted model and not as independent determinant 
(Table 3). 
 
A combination of certain clinical characteristics including obesity, moderate to very 
severe emphysema, severe airflow limitation (FEV1 ≤44% pred.), and resting SpO2 ≤93% 
revealed that the 81% of the subjects with all of these characteristics exhibited EID 
(Figure 3). 
 
 
3.4 Relationship of ADO score with EID 
The presence of EID was related to higher ADO index 27 scores in EID subjects with GOLD 
II-III and across all the degrees of emphysema compared to those with non-EID. For each 
1-point increase on the ADO score, the odds ratio for EID was independently increased by 
1.5 fold while 40% of subjects with ADO ≥6 points had EID (Online table 2). 
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4. Discussion 
This study provides three major observations: (1) about 20% of COPD patients included in 
the ECLIPSE cohort exhibited EID; (2) emphysema, severity of airflow limitation, arterial 
oxygen saturation at rest and obesity are associated with EID; and (3) a high ADO index is 
predictive of EID. 
 
It has been previously suggested that the presence of emphysema may determine EID in 
COPD.11 However, this is the first time that the role of emphysema was investigated in a 
large well-characterized COPD population (ECLIPSE cohort). In this study, emphysema in 
association with other determinants, such as obesity (BMI≥30 kg/m2), have a prognostic 
value in the prediction of EID. Moreover, the relationship of the ADO score with EID was 
a novel investigation. 
 
 
4.1 Interpretation of results 
In current study, the prevalence of EID was increased across the GOLD stages (Figure 1) 
while the severity of airflow limitation seems to contribute to the occurrence of EID more 
than the grades of QCT-emphysema (Figure 2). However, the severity of emphysema was 
more critical for the presence of EID in subjects with GOLD II compared to those with 
more severe airflow limitation. Specifically, the incidence of EID in GOLD II was 
progressively increased across to emphysema degrees (≥9-fold) but this was not the case 
in GOLD III-IV (Figure 2). Ventilation-perfusion inequality (V/Q), which cause EID14, seems 
to be mostly attributed to the degree of emphysema in GOLD II but mostly related to the 
severity of airflow-limitation in GOLD III-IV.  
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In fact, impaired oxygen transport and utilization is a common consequence in both 
airway limitation and pulmonary emphysema, and can lead to ventilation/perfusion (V/Q) 
mismatch resulting in EID. Airflow limitation (impaired FEV1) that often leads to dynamic 
hyperinflation33, 34, and emphysema which is linked to decreased alveolar surface area 
and loss of elastic recoil of the lungs35, 36, can both cause V/Q inequality during exercise 
contributing to the presence of EID.37 Indeed, the negative influence of very low FEV1 
(GOLD III-IV) on oxygen saturation levels, as it is reported in previous studies 5, 38, might 
be overlapping with the contribution of severe emphysema on the occurrence of EID. 
Nevertheless, correlation analysis of this study indicated that emphysema as well as 
airflow limitation similarly correlated to the post-walk SpO2 (r= -0.35 and r= 0.38, 
respectively, p <0.001; Online table 3) and this fact demonstrated that severity of 
emphysema can be also a major determinant of EID, especially in moderate COPD. 
 
In this study, an important finding is that obesity was associated with the presence of EID 
in COPD. Previously, the association of lower SpO2 with obesity has been reported for 871 
emergency department patients and hospital workers.39 Kapur and colleagues have also 
demonstrated that obesity is associated with a lower resting oxygen saturation 
examining a large cohort of 2.252 elderly subjects from the Cardiovascular Health 
Study.40 In COPD, one study confirms a correlation between COPD severity with BMI and 
oxygen saturation using measurements of SpO2 values at rest.
41 To the best of our 
knowledge, our findings revealed for the first time a potential relationship between 
obesity and EID during the 6MWT in subjects with COPD. The direct physiological 
mechanism underlying the effect of obesity on EID is complex; however, obesity and EID 
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could be related to low baseline SpO2, which can be considered as one of the major 
determinant of EID.5, 8  
 
 
 
 
 
In this study, we also investigated the relationship of the ADO index27 and EID. 
Previously, the prognostic value of the ADO index regarding to the risk of exacerbation 
and death have been reported, however, ADO prognostic value of EID has never been 
investigated.42, 43 Multidimensional indices for the prognosis of oxygen desaturation have 
been proposed by Cutaia and colleagues44 who suggested that patients with an 
increased BODE index28 (≥7 points) should be evaluated for oxygen desaturation during 
daily activities.44 In our analysis, the selection of ADO index27 for screening EID was based 
on the fact that exercise or a 6MWT is not required in order to record a score for this 
clinical index. Patients with high score of ADO index27 (≥6 points) presented a greater 
occurrence of EID (40% vs 19%; p <0.001; table 2). This can be attributed to severe airflow 
limitation and/or extended emphysema which was common in those patients with high 
ADO scores. Subjects with EID in GOLD II-III had higher ADO scores compared to non-EID, 
but this was not true in GOLD IV, while ADO scores were also greater in subjects with EID 
across the emphysema severity (Online figure 1). However, we did not include ADO index 
in our multivariate logistical model as age and FEV1, which are the main elements of ADO 
index, were already included as independent determinants in this statistical analysis. 
 
 
 
 
 
 
 
 
 
 
 
In our multivariate logistical regression model, obese subjects with an impaired FEV1 
(≤44%), moderate to very severe emphysema, and low pre-walk SpO2 (≤93%) have higher 
odds for EID (Table 3 and Figure 3). As it was expected, the role of emphysema in EID was 
critical and therefore emphysematous patients should be screened for EID, especially 
those with high ADO scores. 
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4.2 Strengths and weaknesses  
There are certain limitations to our study. First, the 6MWT screening was performed only 
once at baseline, while the 2014 ERS/ATS technical standard for field walking tests 
suggests the conduct of two 6MWT.1 Second, EID was defined based on the SpO2 at the 
end of the test (SpO2 post) and not the SpO2 nadir which can lead to an underestimation 
of the patients who exhibit EID during the 6MWT. Even though SpO2 post and the SpO2 
nadir for most patients with chronic respiratory disease are relatively similar during the 
6MWT45, the use of SpO2 nadir would be optimal absent the biases. Moreover, the 
definition of EID did not include the magnitude of SpO2 degrease, however, only 33 of 
the patients with EID (7.5%) had a SpO2 decline less than 4%. Third, blood gas analysis and 
diffusion capacity (DLCO) were not available in our dataset, which could provide further 
physiological evidence for the presence of EID. Despite these limitations, this study 
contributes with important information about emphysema, airflow limitation and obesity 
as determinants of EID and the use ADO index27 as an additional clinical tool for screening 
EID in patients with COPD. Our findings may help clinicians to better understand the 
relationship of emphysema with EID and predict more accurately the EID. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Conclusions 
 In summary, EID occurs in about 20% of COPD patients. The severity of emphysema in 
moderate COPD increases EID in progressive manner. Several physiological determinants 
including presence of emphysema, severity of airflow limitation, impaired arterial 
oxygenation at rest and obesity, contribute to EID which seems to be captured by high 
ADO index values. Emphysematous patients with high ADO score should be monitored 
for EID upon embarking on a clinical exercise training program. 
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Table Legends 
 
 
 
 
 
 
Table 1: Values expressed as mean ± SD; § One patients had a confirmed diagnosis for 
COPD but could not be assigned to a GOLD stage; §§ in total 183 patient had undefined 
extent of emphysema (% valid percent); #Pearson Chi-Square. Significance level was set at 
P <0.05.  
 
 
Table 2: Values expressed as mean ± SD unless specified otherwise, #Pearson Chi-Square. 
Significance level was set at P <0.05.  
 
 
Table 3: A multivariate-adjusted regression analysis; all the determinants (age, sex, BMI, 
FEV1, emphysema, and SpO2 pre-walk) were included in the multivariate model. 
Significance level was set at P <0.05. 
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TABLES 
 
 
 
BMI: Body Mass Index, FFMI: Fat-Free Mass Index, FEV1: Force Expiratory Volume at 1 sec, FVC: Force Vital 
Capacity, mMRC: modified Medical Research Council Dyspnea Scale, SGRQ-C: St. George’s Respiratory 
Questionnaire for COPD (40-item version) 
 
Table 1. Baseline characteristics of COPD patients categorized by the prevalence of EID 
 
Characteristics All Subjects (n=2050) 
Non-EID 
(n=1615, 79%) 
EID 
(n=435, 21%) 
P 
Value 
Women, #, (%) 710 (35) 544 (34) 166 (38)  
Age, years 63.3 ±7.1 63.1 ± 7.2 64.1 ± 6.8 0.012 
BMI, kg/m2 26.5 ±5.6 26.5 ± 5.5 26.7 ± 5.8 NS 
Underweight 98 (5) 81 (5) 17 (4)  
Normal range 751 (37) 591 (36) 160 (37)  
Overweight 743 (36) 594 (37) 149 (34)  
Obese 458 (22) 349 (22) 109 (25) NS# 
FFMI, kg/m2 17.8 ±3.4 17.8 ± 3.5 17.6 ± 3.4 NS 
FEV1, % predicted 48.7 ±15.7 51.2 ± 15.2 39.5 ± 13.9 <0.001 
FVC, % predicted 80.0 ±19.8 81.2 ± 19.2  75.4 ± 21.0 <0.001 
FEV1/FVC, % 44.7 ±11.4 46.2 ± 11.0 39.1 ± 11.1 <0.001 
GOLD Classification§ 
       
Stage II 925 (45) 836 (52) 89 (20)  
Stage III 861 (42) 639 (39) 222 (51)  
Stage IV 263 (13) 139 (9) 124 (29) <0.001# 
Emphysema extent §§        
 <5%      [absent-trivial] 478 (26) 431 (30) 47 (11)  
 5-25%    [Mild] 406 (22) 356 (24) 50 (12)  
 25-50% [Moderate] 361 (19) 293 (20) 68 (17)  
>50%     [Severe-very severe] 622 (33) 375 (26) 247 (60) <0.001# 
mMRC, Dyspnoea.grade  1.7 ± 1.0 1.6 ± 1.0 2.0 ± 1.0 <0.001 
 ≥2  1062 (53) 775 (48) 287 (66) <0.001# 
SGRQ-C Total Score 47.8 ± 18.1 46.5 ± 18.5 52.6 ± 15.6 <0.001 
≥50 points, n (%) 934 (47) 700 (43) 234 (54)  
Current Smokers, n   (%) 742 (36) 639 (40) 103 (24) <0.001# 
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6MWD: Six-min walk distance, SpO2: Oxygen saturation, HR: Heart rate, ADO index: “Age, Dyspnoea, and 
airflow Obstruction”, BODE index: “Body-mass index, airflow Obstruction, Dyspnea, and Exercise”,           
EID: Exercise-induced oxygen desaturation (SpO2 post ≤88%) 
 
 
Table 2.  Six-Minute Walk Test characteristics and multi-dimensional indices categorized by 
the prevalence of EID 
 
Characteristics 
All Subjects 
(n=2050) 
Non-EID 
(n=1615, 79%) 
EID 
(n=435, 21%) 
P 
Value 
 
6MWD, m, ±SD 372 ±121 382 ±119 334 ±12 <0.001 
6MWD, % predicted 64 ±21 66 ±20 58 ±21 <0.001 
SpO2, % pre 94.7 ±2.2 95.1 ±2.0 93.1 ±2.3 <0.001 
SpO2, % post 91.8 ±5.0 93.9 ±2.6 84.1 ±4.3 <0.001 
SpO2, %  -2.9 ±4.3 -1.2 ±2.4 -9.0 ±4.8 <0.001 
 
HR pre, b/m  82 ±14 81 ±14 85 ±14 <0.001 
HR post, b/m 100 ±18 98 ±17 108 ±19 <0.001 
HR, b/m  18 ±14 17 ±13 23 ±16 <0.001 
Borg Scale 
       
Dyspnoea, pre 1.6 ±1.8 1.5 ±1.8 1.7 ±1.9 NS 
Dyspnoea , post 3.9 ±2.4 3.6 ±2.3 4.7 ±2.3 <0.001 
Dyspnoea 2.3 ±2.0 2.1 ±1.9 3.0 ±2.2 <0.001 
Fatigue , pre 1.3 ±1.8 1.3 ±1.8 1.3 ±1.8 NS 
Fatigue, post 2.7 ±2.5 2.6 ±2.5 2.7 ±2.5 NS 
Fatigue 1.4 ±1.9 1.4 ±1.8 1.4 ±1.9 NS 
ADO index, score 3.7 ±1.5 3.5 ±1.5 4.4 ±1.4 <0.001 
≥6 points, n, (%) 245 (12) 148 (9) 97 (22) <0.001
# 
BODE index, score 3.1 ±2.1 2.8 ±2.0 4.2 ±2.1 <0.001 
≥6 points, n, (%) 456 (22) 286 (18) 170 (39) <0.001# 
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Table 3.  Logistic regression: Determinants of EID in COPD patients 
 
 
       Determinants 
   Subjects  
  n 
EID                  
n, (% )      
Crude OR      
(95%CI) 
    P 
value 
Adjust OR 
(95%CI) 
P 
value 
Age 
      <60 years   594 106 (18) 1 
 
1 
 ≥60 years   1456 329 (23) 1.34 (1.05-1.71) 0.017 1.21 (0.91-1.61) NS 
Sex 
      Male 1340 269 (20) 1 
 
1 
 Female 710 166 (23) 1.22 (0.98-1.51) NS 1.30 (1.00-1.68) NS 
BMI 
      <30 kg/m2 1592 326 (20) 1 
 
1 
 ≥30 kg/m2 458 109 (24) 1.21 (0.95-1.55) NS 1.57 (1.15-2.14) 0.005 
FEV1 
      >44%   1198 141 (12) 1 
<0.001 
1 
<0.001 ≤44%    851 294 (35) 3.96 (3.16-4.96) 3.14 (2.42-4.07) 
              Emphysema 
     Absent to mild   884 97 (11) 1 
 
1 
 Moderate to very severe  983 315 (32) 3.83 (2.98-4.91) <0.001 3.37 (2.52-4.51) <0.001 
SpO2% pre-walk 
      >93% 1506 194 (13) 1 
 
1 
 ≤93% 544 241 (44) 5.38 (4.29-6.75) <0.001 4.75 (3.69-6.13) <0.001 
 
BMI: Body Mass Index, FEV1: Force Expiratory Volume at 1 sec, SpO2: Oxygen saturation. Multivariate-
adjusted model including all the determinants. 
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Figure Legends 
 
Figure 1. EID progressively increased across the GOLD stages in COPD. A total of 435 
subjects (21%) in the ECLIPSE cohort exhibited EID.  
 
Figure 2. Frequency distribution of post-walk SpO2   and EID (≤88%) stratified by the GOLD 
stages and the degrees of QCT-emphysema. The dot line marks the threshold value for 
the presence of EID (SpO2 post-walk ≤88%).  
 
Figure 3. A combination of certain lung function and baseline oxygen saturation 
characteristics for the prediction of EID revealed that the highest proportion of patients 
(81%) who exhibit EID are characterized by moderate to very severe emphysema (QCT 
score 3-5), obesity, impaired FEV1 and low resting values of SpO2 pre-walk. 
 
Online figure 1. Comparisons of ADO index between EID and non-EID across the GOLD 
stages and the degrees of QCT-emphysema. Asterisks denotes significant difference              
(* p< 0.05; ** p< 0.001). 
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